Submit Your Information

If you suffered a loss on your DaVita Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Are you a current or former employee of the company?*

YesNo

Purchases
Sales

Purchases

+Additional Purchases

Sales

+Additional Sales

On October 20, 2026, the U.S. Department of Health and Human Services (“HHS”) announced its Kidney Care National Plan. Among other things, the HHS stated the combined market share of the two largest dialysis chains, DaVita and Fresenius Medical Care, control approximately 74% of the market, and the HHS would be investigating potential anticompetitive payment and legal strategies used by the largest firms to garner larger reimbursements without providing superior patient care.

On this news, DaVita’s stock fell $11.65 or 6.23%, to close at $175.35 on October 20, 2026, thereby injuring investors.

Submit Your Information